Protalix BioTherapeutics (PLX) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,987.00 |
| Dec 31, 2025 | -3,652.00 |
| Sep 30, 2025 | -2,005.00 |
| Jun 30, 2025 | -2,083.00 |
| Mar 31, 2025 | -6,506.00 |
| Dec 31, 2024 | -23.00 |
| Sep 30, 2024 | -2,414.00 |
| Jun 30, 2024 | -4,817.00 |
| Mar 31, 2024 | -4,983.00 |
| Dec 31, 2023 | 4,527.00 |
| Sep 30, 2023 | 24,184.00 |
| Jun 30, 2023 | 9,130.00 |
| Mar 31, 2023 | 3,205.00 |
| Dec 31, 2022 | 2,135.00 |
| Sep 30, 2022 | 3,072.00 |
| Jun 30, 2022 | 4,017.00 |
| Mar 31, 2022 | 1,382.00 |
| Dec 31, 2021 | 5,698.00 |
| Sep 30, 2021 | 6,024.00 |
| Jun 30, 2021 | 2,104.00 |
| Mar 31, 2021 | 3,493.00 |
| Sep 30, 2020 | -989.00 |
| Jun 30, 2020 | 18.00 |
| Mar 31, 2020 | 84.00 |
| Mar 31, 2019 | 3,098.00 |
| Dec 31, 2018 | -11,000.00 |
| Sep 30, 2018 | -26,672.00 |
| Jun 30, 2018 | -8,594.00 |
| Mar 31, 2018 | -4,822.00 |
| Dec 31, 2017 | 14,725.00 |
| Sep 30, 2017 | -6,178.00 |
| Jun 30, 2017 | -7,104.00 |
| Mar 31, 2017 | -1,370.00 |
| Dec 31, 2016 | -625.00 |
| Sep 30, 2016 | -5,077.00 |
| Jun 30, 2016 | 62,704.00 |
| Mar 31, 2016 | -10,353.00 |
| Sep 30, 2015 | 1,676.00 |
| Jun 30, 2015 | 2,943.00 |